Rahul Sasané
YOU?
Author Swipe
View article: A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups
A Qualitative Study on Perspectives of Parkinson’s Disease Medications: Insights from Patient Focus Groups Open
This study identified four core dimensions associated with PD medications from the perspective of PwPD. Results indicate the need for enhanced communication between providers and patients regarding PD medication to reduce the uncertainties…
View article: Association Between Persistence with Oral Atypical Antipsychotic Medications and Hospital and Emergency Department Utilization in Medicaid Patients with Schizophrenia
Association Between Persistence with Oral Atypical Antipsychotic Medications and Hospital and Emergency Department Utilization in Medicaid Patients with Schizophrenia Open
Non-persistence with OAAP medication is common among patients with schizophrenia and associated with negative outcomes including increased utilization of hospital and ED resources. Patient-centered interventions that improve antipsychotic …
View article: One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication
One-Year Medication Treatment Patterns, Healthcare Resource Utilization, and Expenditures for Medicaid Patients with Schizophrenia Starting Oral Atypical Antipsychotic Medication Open
View article: Treatment Patterns and Healthcare Resource Use in Medicare Beneficiaries with Parkinson’s Disease
Treatment Patterns and Healthcare Resource Use in Medicare Beneficiaries with Parkinson’s Disease Open
While levodopa is still the mainstay of PD management, considerable heterogeneity exists in real-world treatment patterns. Overall, PD symptoms and AEs were associated with significantly higher HRU and healthcare costs, suggesting unmet me…
View article: Work Loss and Direct and Indirect Costs Associated with Parkinson’s Disease
Work Loss and Direct and Indirect Costs Associated with Parkinson’s Disease Open
PD has both a significant direct and indirect financial burden on patients and their spouses when analyzed for 3 years before and after diagnosis.
View article: Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
Dopamine agonist monotherapy utilization in patients with Parkinson’s disease Open
View article: Exploring access to care from the perspective of patients with breast cancer: A qualitative study
Exploring access to care from the perspective of patients with breast cancer: A qualitative study Open
Objectives Patients face a myriad of personal and system‐based challenges in accessing breast cancer care, but less is known about access as expressed and experienced by patients themselves. The objective of this qualitative study was to f…
View article: Levodopa treatment patterns in Parkinson’s disease: A retrospective chart review
Levodopa treatment patterns in Parkinson’s disease: A retrospective chart review Open
Prescribers and patients tend to experiment with levodopa-PDDI treatment. Although many patients appeared to stop levodopa-PDDI after an initial course of treatment, most subsequently restarted treatment.
View article: Natural history and patterns of treatment change in Parkinson’s disease: A retrospective chart review
Natural history and patterns of treatment change in Parkinson’s disease: A retrospective chart review Open
View article: Parkinson disease among patients treated for benign prostatic hyperplasia with α1 adrenergic receptor antagonists
Parkinson disease among patients treated for benign prostatic hyperplasia with α1 adrenergic receptor antagonists Open
BACKGROUNDRecently the α1 adrenergic receptor antagonist terazosin was shown to activate PGK1, a possible target for the mitochondrial deficits in Parkinson disease related to its function as the initial enzyme in ATP synthesis during glyc…
View article: An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population
An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population Open
View article: Evaluation of access to care issues in patients with breast cancer
Evaluation of access to care issues in patients with breast cancer Open
Access to care overall and by factor was significantly predictive of patient satisfaction with care. In addition, access to care factors varied across several demographic and clinical characteristics. Future strategies that address access …
View article: Drug Treatment Value in a Changing Oncology Landscape: A Literature and Provider Perspective
Drug Treatment Value in a Changing Oncology Landscape: A Literature and Provider Perspective Open
Funding for this work was provided by Novartis Pharmaceuticals. The study sponsor was involved in study design, data interpretation, and data review. All authors contributed to the development of the manuscript and maintained control over …
View article: A Review Of Factors Associated With Access To Care In Breast Cancer Patients
A Review Of Factors Associated With Access To Care In Breast Cancer Patients Open
View article: Medical Resource Utilization and Expenditures in Texas Medicaid Patients Taking Deferasirox Dispersible Tablets and Those Taking Deferasirox Film-Coated Tablets
Medical Resource Utilization and Expenditures in Texas Medicaid Patients Taking Deferasirox Dispersible Tablets and Those Taking Deferasirox Film-Coated Tablets Open
View article: Outcomes-Based Contracting Experience: Research Findings from U.S. and European Stakeholders
Outcomes-Based Contracting Experience: Research Findings from U.S. and European Stakeholders Open
This study was funded by Novartis Pharmaceuticals. Novartis employees were involved in all aspects of this study. Vegesna and Sasane are employed by and own stock in Novartis. Nazareth and Ko were employees of Novartis at the time of this …
View article: Associations Between Treatment Satisfaction, Medication Beliefs, and Adherence to Disease-Modifying Therapies in Patients with Multiple Sclerosis
Associations Between Treatment Satisfaction, Medication Beliefs, and Adherence to Disease-Modifying Therapies in Patients with Multiple Sclerosis Open
Background: Adherence to disease-modifying therapy (DMT) remains problematic for many patients with multiple sclerosis (MS). An improved understanding of factors affecting DMT adherence may inform effective interventions. This study examin…
View article: Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review Open
View article: The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis Open
View article: Increasing Patient Involvement in Drug Development
Increasing Patient Involvement in Drug Development Open
As health care systems continue to evolve and establish patients as the primary stakeholder in their health care decision making, the pharmaceutical industry will need to be innovative to demonstrate the value of their products relative to…
View article: Prevalence And Incidence Of Attention Deficit Hyperactivity Disorder Among Texas Medicaid Preschoolers
Prevalence And Incidence Of Attention Deficit Hyperactivity Disorder Among Texas Medicaid Preschoolers Open
View article: OUTCOMES-BASED ARRANGEMENTS IN VALUE-BASED CARE: AN ENGAGEMENT FRAMEWORK
OUTCOMES-BASED ARRANGEMENTS IN VALUE-BASED CARE: AN ENGAGEMENT FRAMEWORK Open
View article: Additional file 1: of Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review
Additional file 1: of Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review Open
Multiple sclerosis patients receiving oral disease-modifying therapies medical record review. Data file contains multiple-sclerosis patient medical record reviews. Each row is a distinct patient. Columns reflect information about the patie…
View article: Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis
Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis Open
View article: Preferred Features of Oral Treatments and Predictors of Non-Adherence: Two Web-Based Choice Experiments in Multiple Sclerosis Patients
Preferred Features of Oral Treatments and Predictors of Non-Adherence: Two Web-Based Choice Experiments in Multiple Sclerosis Patients Open
Understanding the important concerns expressed by patients may help health care providers to understand and educate their patients more completely about these concerns. This knowledge may therefore improve both choices of appropriate thera…